Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa

Diagnostic Microbiology and Infectious Disease

Volumn 69, Issue 4, 2011, Pages 449-453

  Peirano, Gisele ^a   van Greune, Cornelius H J ^b   Pitout, Johann D D ^a,c  

^a CALGARY LABORATORY SERVICES   (Canada)

^b Ampath Pathology Laboratories   (South Africa)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

CTX M; E. coli; ST131; Urinary tract infections

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE CTX M; BETA LACTAMASE OXA; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CEFOXITIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ABDOMINAL ABSCESS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BURN INFECTION; CLINICAL ARTICLE; COMMUNITY HOSPITAL; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HUMAN; ISOELECTRIC FOCUSING; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SOUTH AFRICA; URINARY TRACT INFECTION;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; COHORT STUDIES; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HOSPITALS, COMMUNITY; HUMANS; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; SOUTH AFRICA;

EID: 79952374795     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.11.011     Document Type: Article

References (28)

1. Bell J.M., Turnidge J.D., Gales A.C., Pfaller M.A., Jones R.N. Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn. Microbiol. Infect. Dis. 2002, 42:193-198.
2. Bouchillon S.K., Johnson B.M., Hoban D.J., Johnson J.L., Dowzicky M.J., Wu D.H., Visalli M.A., Bradford P.A. Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. Int. J. Antimicrob. Agents 2004, 24:119-124.
3. Brink A., Moolman J., da Silva M.C., Botha M. Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa. S. Afr. Med. J. 2007, 97:273-279.
4. Clermont O., Bonacorsi S., Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 2000, 66:4555-4558.
5. Clermont O., Lavollay M., Vimont S., Deschamps C., Forestier C., Branger C., Denamur E., Arlet G. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J. Antimicrob. Chemother. 2008, 61:1024-1028.
6. Clermont O., Dhanji H., Upton M., Gibreel T., Fox A., Boyd D., Mulvey M.R., Nordmann P., Ruppé E., Sarthou J.L., Frank T., Vimont S., Arlet G., Branger C., Woodford N., Denamur E. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 2009, 64:274-277.
7. CLSI Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement 2009, CLSI, Wayne.
8. Coque T.M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., Baquero F., Canton R., Nordmann P. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 2008, 14:195-200.
9. Dahmen S., Bettaieb D., Mansour W., Boujaafar N., Bouallegue O., Arlet G. Characterization and molecular epidemiology of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in a Tunisian University Hospital. Microb Drug Resist 2010, 16:163-170.
10. Ehlers M.M., Veldsman C., Makgotlho E.P., Dove M.G., Hoosen A.A., Kock M.M. Detection of blaSHV, blaTEM and blaCTX-M antibiotic resistance genes in randomly selected bacterial pathogens from the Steve Biko Academic Hospital. FEMS Immunol. Med. Microbiol. 2009, 56:191-196.
11. Elliott E., Brink A.J., van Greune J., Els Z., Woodford N., Turton J., Warner M., Livermore D.M. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase. Clin. Infect. Dis. 2006, 42:e95-e98.
12. Govender N., Smith A.M., Karstaedt A.S., Keddy K.H. Plasmid-mediated quinolone resistance in Salmonella from South Africa. J. Med. Microbiol. 2009, 58:1393-1394.
13. Govinden U., Mocktar C., Moodley P., Sturm A.W., Essack S.Y. CTX-M-37 in Salmonella enterica serotype Isangi from Durban, South Africa. Int. J. Antimicrob. Agents 2006, 28:288-291.
14. Hirakata Y., Matsuda J., Miyazaki Y., Kamihira S., Kawakami S, Miyazawa Y., Ono Y., Nakazaki N., Hirata Y., Inoue M., Turnidge J.D., Bell J.M., Jone R.N., Kohno S., SENTRY Asia-Pacific Participants Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn. Microbiol. Infect. Dis. 2005, 52:323-329.
15. Hunter S.B., Vauterin P., Lambert-Fair M.A., Van Duyne M.S., Kubota K., Graves L., Wrigley D., Barrett T., Ribot E. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J. Clin. Microbiol. 2005, 43:1045-1050.
16. Nicolas-Chanoine M.H., Blanco J., Leflon-Guibout V., Demarthy R., Alonso M.P., Caniça M.M., Park Y.J., Lavigne J.P., Pitout J., Johnson J.R. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 2008, 61:273-281.
17. Park C.H., Robicsek A., Jacoby G.A., Sahm D., Hooper D.C. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents. Chemother. 2006, 50:3953-3955.
18. Paterson D.L., Hujer K.M., Hujer A.M., Yeiser B., Bonomo M.D., Rice L.B., Bonomo R.A. Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases. Antimicrob Agents. Chemother. 2003, 47:3554-3560.
19. Peirano G., Costello M., Pitout J.D. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Int. J. Antimicrob. Agents 2010, 36:19-23.
20. Peirano G., Pitout J.D. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 2010, 35:316-321.
21. Pitout J.D., Church D.L., Gregson D.B., Chow B.L., McCracken M., Mulvey M.R., Laupland K.B. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob Agents. Chemother. 2007, 51:1281-1286.
22. Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 2008, 8:159-166.
23. Pitout J.D., Gregson D.B., Campbell L., Laupland K.B. Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents. Chemother. 2009, 53:2846-2851.
24. Robicsek A., Strahilevitz J., Jacoby G.A., Macielag M., Abbanat D., Park C.H., Bush K., Hooper D.C. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 2006, 12:83-88.
25. Robicsek A., Strahilevitz J., Sahm D.F., Jacoby G.A., Hooper D.C. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 2006, 50:2872-2874.
26. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 1995, 33:2233-2239.
27. Usha G., Chunderika M., Prashini M., Willem S.A., Yusuf E.S. Characterization of extended-spectrum beta-lactamases in Salmonella spp. at a tertiary hospital in Durban, South Africa. Diagn. Microbiol. Infect. Dis. 2008, 62:86-91.
28. Yamane K., Wachino J., Suzuki S., Arakawa Y. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob. Agents Chemother. 2008, 52:1564-1566.